Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa
Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa
About this item
Full title
Author / Creator
REALITY Trial Team , Hakim, James , Musiime, Victor , Szubert, Alex J , Mallewa, Jane , Siika, Abraham , Agutu, Clara , Walker, Simon , Pett, Sarah L , Bwakura-Dangarembizi, Mutsa , Lugemwa, Abbas , Kaunda, Symon , Karoney, Mercy , Musoro, Godfrey , Kabahenda, Sheila , Nathoo, Kusum , Maitland, Kathryn , Griffiths, Anna , Thomason, Margaret J , Kityo, Cissy , Mugyenyi, Peter , Prendergast, Andrew J , Walker, A. Sarah and Gibb, Diana M
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
High mortality is associated with initiation of antiretroviral therapy for HIV. In this report from sub-Saharan Africa, enhanced prophylaxis with isoniazid, fluconazole, azithromycin, and albendazole was associated with decreased mortality at 24 and 48 weeks.
Alternative Titles
Full title
Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa
Authors, Artists and Contributors
Author / Creator
Hakim, James
Musiime, Victor
Szubert, Alex J
Mallewa, Jane
Siika, Abraham
Agutu, Clara
Walker, Simon
Pett, Sarah L
Bwakura-Dangarembizi, Mutsa
Lugemwa, Abbas
Kaunda, Symon
Karoney, Mercy
Musoro, Godfrey
Kabahenda, Sheila
Nathoo, Kusum
Maitland, Kathryn
Griffiths, Anna
Thomason, Margaret J
Kityo, Cissy
Mugyenyi, Peter
Prendergast, Andrew J
Walker, A. Sarah
Gibb, Diana M
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5603269
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5603269
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1615822
